Actavis/Warner Chilcott: Following more than a week of speculation, generics giant Actavis Group agreed to purchase specialty pharma Warner Chilcott PLC on May 20 in an all-stock transaction under which Warner shareholders will end up with a 23 ...

Under the terms of the deal, Novo will purchase all shares in Oslo-based Xellia, taking it off the hands of British venture capital company 3i Group PLC and other investors and moving Xellia's headquarters to Copenhagen. The deal is expected to close ...